Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
Leveraging Social Determinants Via Artificial Intelligence and Peer Coaching to Address Racial Disparities in Primary Care Among People Who Use Opioids
1 other identifier
interventional
292
1 country
1
Brief Summary
Black and Latinx people who use opioids are disproportionately impacted by opioid overdose deaths. The proposed study assesses the efficacy of an open source, multimodal artificial intelligence-driven texting tool combined with peer recovery coach-supported text contact that delivers social services, stigma reduction, health habitus, and patient navigation content addressing social determinants of health to enhance receipt of buprenorphine in primary care among emergency department-enrolled Black / Latinx people who use opioids.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2024
CompletedFirst Posted
Study publicly available on registry
August 26, 2024
CompletedStudy Start
First participant enrolled
March 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
ExpectedAugust 12, 2025
September 1, 2024
5 months
August 12, 2024
August 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of self-reported linkage to OUD services
The primary outcome for this efficacy study is self-reported linkage to OUD services (i.e., time to initial buprenorphine prescription that is prescribed in OBOT programs or other OUD treatment providers per the Non-study Medical and Other Services form.
1 year
Secondary Outcomes (3)
Number of Office-Based Opioid Treatment with buprenorphine.
1 year
Number of social services received
1 year
Number of interactions and time spent (in minutes) engaged with the intervention
26 weeks
Study Arms (3)
Intervention Arm-1: PRC supported text+ AI driven SDH-enhanced text
EXPERIMENTALParticipants in this arm will receive a combination of Peer Recovery Coaches (PRCs) supported text-based care/services coordination alongside AI-driven SDH-enhanced text messages to enhance the receipt of buprenorphine in Black/ Latin people who use opioids.
Intervention Arm-2: AI driven SDH-enhanced text only
EXPERIMENTALParticipants in this arm will receive AI-driven SDH-enhanced text messages to enhance the receipt of buprenorphine in Black/ Latin people who use opioids. Unlike Arm-1, this intervention does not include the additional support and coordination provided by Peer Recovery Coaches.
Control Arm 3- Treatment as Usual
PLACEBO COMPARATORControl Arm-3 will receive treatment as usual (i.e., verbal instructions, NYC Dept of Health pamphlets detailing access to OUD and social services, health system smartphone application EMR patient portal).
Interventions
This interventional study evaluates an AI-driven texting tool combined with peer recovery coach support to deliver social services, reduce stigma, and provide patient navigation content. The goal is to enhance the receipt of buprenorphine in primary care among emergency department-enrolled Black and Latinx individuals who use opioids, addressing the disproportionate impact of opioid overdose deaths on these communities.
This interventional study evaluates an AI-driven SDH-enhanced texting tool to deliver social services, reduce stigma, and provide patient navigation content. The goal is to enhance the receipt of buprenorphine in primary care among emergency department-enrolled Black and Latinx individuals who use opioids, addressing the disproportionate impact of opioid overdose deaths on these communities.
Control Arm-3 will receive treatment as usual (i.e., verbal instructions, NYC Dept of Health pamphlets detailing access to OUD and social services, health system smartphone application EMR patient portal).
Eligibility Criteria
You may qualify if:
- ≥18 years of age;
- fluent in English and/or Spanish;
- self-reported non-prescription opioid use \<30 days prior to consent;
- provision of informed consent;
- planned stay in NYC ≥12 month;
- self-identified Black and/or Latinx race/ethnicity;
- positive urine toxicology for opioids per EMR records;
- diagnosis of OUD per the Diagnostic and Statistical Manual of Mental Disorders-5
- self-reported interest in initiating buprenorphine in primary care
- must have a mobile phone data plan.
You may not qualify if:
- inability to comprehend text content written at a 3rd grade reading level;
- physical or visual disability preventing mobile phone use;
- self-reported receipt of medications for OUD in past 30 days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Friends Research Institute, Inc.lead
- Nathan Kline Institute for Psychiatric Researchcollaborator
- NYU Langone Healthcollaborator
- Weill Medical College of Cornell Universitycollaborator
Study Sites (1)
NYC Health + Hospitals
The Bronx, New York, 10451, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Babak Tofighi, MSc, MD
Friends Research Institute, Inc.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2024
First Posted
August 26, 2024
Study Start
March 28, 2025
Primary Completion
August 31, 2025
Study Completion (Estimated)
August 31, 2026
Last Updated
August 12, 2025
Record last verified: 2024-09